Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease?
- PMID: 25377235
- DOI: 10.1002/cncr.29129
Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease?
Abstract
Background: Previous reports have described differences in biology and outcome for colorectal cancer based on whether the primary is right or left sided. Further division by right, left, and rectum or even exact primary site has also been explored. Possible differences in response to biological agents have also been reported based on side of primary lesion.
Methods: We explored the South Australian registry for metastatic colorectal cancer to assess if there were any differences in patient characteristics, prognostic markers, and treatment received and outcomes based on whether the primary was right or left sided. We also explored if differences exist based on left colon and rectum and by exact primary site.
Results: Two thousand nine hundred seventy-two patients were analyzed. Thirty-five percent had a right-sided primary. The median overall survival for the entire group right versus left was 9.6 versus 20.3 months (P < .001). Multivariate analysis confirmed side of primary as an independent prognostic factor. For the group that had active therapy, defined as chemotherapy (± metastasis resection), median overall survival was right, 18.2 months; and left, 29.4 months (P < .001). Importantly, we found no suggestion of major differences if left side was divided by left colon and rectum, and trends by individual site still supported a left and right division.
Conclusions: Patients with a right-sided primary have more negative prognostic factors and indeed have inferior outcomes compared with those with a left-sided primary. Our data with further breakdown by exact site still favor a simple left-versus-right division moving forward for metastatic colorectal cancer.
Keywords: colorectal cancer; primary site; registry; survival.
© 2014 American Cancer Society.
Similar articles
-
Right or Left Primary Site of Colorectal Cancer: Outcomes From the Molecular Analysis of the AGITG MAX Trial.Clin Colorectal Cancer. 2019 Jun;18(2):141-148. doi: 10.1016/j.clcc.2018.12.002. Epub 2019 Jan 3. Clin Colorectal Cancer. 2019. PMID: 30713134
-
Impact of Primary Tumor Site on Bevacizumab Efficacy in Metastatic Colorectal Cancer.Clin Colorectal Cancer. 2016 Jun;15(2):e9-e15. doi: 10.1016/j.clcc.2016.02.007. Epub 2016 Feb 13. Clin Colorectal Cancer. 2016. PMID: 26968236
-
A population-based study of metastatic colorectal cancer in individuals aged ≥ 80 years: findings from the South Australian Clinical Registry for Metastatic Colorectal Cancer.Cancer. 2013 Feb 15;119(4):722-8. doi: 10.1002/cncr.27802. Epub 2012 Sep 18. Cancer. 2013. PMID: 22990939
-
Histopathologic prognostic factors in resected colorectal lung metastases.Ann Thorac Surg. 2005 Jan;79(1):278-82; discussion 283. doi: 10.1016/j.athoracsur.2004.06.096. Ann Thorac Surg. 2005. PMID: 15620957 Review.
-
Difference between right-sided and left-sided colorectal cancers: from embryology to molecular subtype.Expert Rev Anticancer Ther. 2018 Apr;18(4):351-358. doi: 10.1080/14737140.2018.1442217. Epub 2018 Feb 19. Expert Rev Anticancer Ther. 2018. PMID: 29458272 Review.
Cited by
-
Long-term survival after hepatic resection for colorectal liver metastases: a single-center study in Iran.BMC Surg. 2024 May 3;24(1):131. doi: 10.1186/s12893-024-02420-4. BMC Surg. 2024. PMID: 38702645 Free PMC article.
-
Loss of Y in regulatory T lymphocytes in the tumor micro-environment of primary colorectal cancers and liver metastases.Sci Rep. 2024 Apr 24;14(1):9458. doi: 10.1038/s41598-024-60049-y. Sci Rep. 2024. PMID: 38658633 Free PMC article.
-
Colorectal Cancer: Disease Process, Current Treatment Options, and Future Perspectives.Pharmaceutics. 2023 Nov 12;15(11):2620. doi: 10.3390/pharmaceutics15112620. Pharmaceutics. 2023. PMID: 38004598 Free PMC article. Review.
-
Using the win ratio to compare laparoscopic versus open liver resection for colorectal cancer liver metastases.Hepatobiliary Surg Nutr. 2023 Oct 1;12(5):692-703. doi: 10.21037/hbsn-22-36. Epub 2022 Jun 20. Hepatobiliary Surg Nutr. 2023. PMID: 37886182 Free PMC article.
-
Primary tumor resection improves prognosis of unresectable carcinomas of the transverse colon including flexures with pulmonary metastasis: a cohort study.Eur J Cancer Prev. 2024 Mar 1;33(2):95-104. doi: 10.1097/CEJ.0000000000000841. Epub 2023 Oct 9. Eur J Cancer Prev. 2024. PMID: 37823436 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical